Hair loss breakthrough? study tests top treatments for CCCA
NCT ID NCT04207931
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 250 African-American women with a type of scarring hair loss called CCCA. Researchers will compare how well different treatments—like steroid creams, steroid injections, an oral antibiotic, and minoxidil—work over 18 months. The goal is to see which approach best slows hair loss and encourages regrowth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Topical steroids (clobetasol, betamethasone, fluocinonide), triamcinolone acetonide injections, doxycycline, minoxidil
What this could lead to
If successful, this study could identify which combination of treatments works best to stop hair loss and promote regrowth in women with CCCA.
What could go wrong
This is an observational comparison of existing treatments, not a test of a new drug. Results may not apply to all patients, and some treatments have side effects like skin thinning or antibiotic resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA (CCCA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest Baptist Health Department of Dermatology
RECRUITINGWinston-Salem, North Carolina, 27157, United States